Clinical trial
Effectiveness and Cost-effectiveness of Lymphaticovenous Anastomosis for Cancer Patients Who Suffer From Chronic Peripheral Lymphedema: a Randomized Controlled Trial
NCT06082349 is registered in ClinicalTrials.gov with Maastricht University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effectiveness and Cost-effectiveness of Lymphaticovenous Anastomosis for Cancer Patients Who Suffer From Chronic Peripheral Lymphedema: a Randomized Controlled Trial
- Lead sponsor
- Maastricht University Medical Center
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- December 18, 2023
- Completion date
- March 1, 2029
- Enrollment
- 110 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
lymphedema arm, lymphedema of leg, lymphedema of upper limb, lymphedema, lower limb, lymphedema, secondary